CLINICAL_TRIALS
trial_result
· 2026-07-13
Clinical Trial Results: Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis [Phase 2]
Summary
Phase 2 proof-of-concept study evaluating rilzabrutinib in adults with moderate-to-severe atopic dermatitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2026-07-13